Unimate (Yerba Mate) Stimulates Natural GLP-1 Production via Gut Microbiome

يونيماتي (يربا ماتي) يحفز إنتاج هرمون GLP-1 الطبيعي عبر ميكروبيوم الأمعاء

Journal: Nutrients (MDPI)

University: Brigham Young University

Study Type: preclinical

Evidence Level: moderate

Participants: 12

Published:

⚠️ Warning: This is a preliminary study (animal/cell) and has not been proven in humans.

30-Second Summary

A recent study from Brigham Young University revealed that yerba mate extract (the key ingredient in Unicity Unimate) naturally increases GLP-1 production through interaction with gut bacteria. Dihydroferulic acid, a microbial metabolite of ferulic acid found in yerba mate, more than doubled GLP-1 secretion (2.5x) in intestinal L-cells. This means Unimate works through a mechanism similar to expensive GLP-1 medications but in a completely natural way.

1-Minute Summary

Researchers from Brigham Young University conducted an innovative study to understand how yerba mate drink affects satiety hormones and metabolism. The team used laboratory mice fed yerba mate extract (provided by Unicity International) for four weeks. Key Results: • GLP-1 gene expression significantly increased in the intestine compared to controls • Plasma GLP-1 levels rose substantially • Dihydroferulic acid (a bacterial metabolite of ferulic acid) more than doubled GLP-1 secretion (2.5x) • GIP hormone was unaffected, indicating a selective and specific mechanism Scientific Significance: GLP-1 is the same hormone targeted by modern obesity drugs like semaglutide (Ozempic/Wegovy). This study proves that yerba mate can stimulate the same hormonal pathway naturally through the gut microbiome.

3-Minute Summary

# Comprehensive Study: Yerba Mate and GLP-1 Stimulation via Gut Microbiome ## Research Background Incretin hormones (GLP-1 and GIP) play a pivotal role in regulating glucose levels, appetite, and energy balance. GLP-1 is secreted from intestinal L-cells in response to food, enhances glucose-dependent insulin secretion, delays gastric emptying, and promotes satiety. Incretin dysfunction is implicated in obesity and type 2 diabetes. GLP-1 receptor agonist medications (like semaglutide) have shown robust efficacy but are expensive and may cause gastrointestinal side effects. Scientists are therefore seeking natural alternatives. ## Study Design - **Institution:** Brigham Young University, Utah, USA - **Publication:** Nutrients (MDPI), February 2025 - **Design:** Preclinical study (animal + cell-based) - **Duration:** 4 weeks of yerba mate supplementation - **Source:** Yerba mate extract provided by Unicity International ## Methodology C57BL/6 mice (male and female) were randomly divided into two groups: yerba mate and control (water). After 4 weeks, GLP-1 and GIP gene expression was analyzed in jejunal mucosa, and plasma hormone concentrations were measured. In vitro experiments were also conducted on GLUTag L-cells. ## Detailed Results 1. **GLP-1 Increase:** Gene expression and plasma levels significantly elevated vs controls 2. **Microbiome Mechanism:** Direct cell treatment with yerba mate did NOT enhance GLP-1, but dihydroferulic acid (bacterial metabolite) powerfully stimulated production (>2.5x) 3. **Selectivity:** GIP was unaffected, indicating a gut-specific mechanism 4. **Ferulic Acid:** A key phenolic compound in yerba mate, converted by gut bacteria into the more potent dihydroferulic acid ## Conclusions Yerba mate selectively upregulates GLP-1 pathways without affecting GIP, likely through gut-mediated mechanisms. These findings suggest yerba mate as a promising nutraceutical for incretin modulation and metabolic disorder management. ## Connection to Unimate Unicity's Unimate uses an advanced extraction process that preserves bioactive compounds like ferulic acid and chlorogenic acids. The study actually used yerba mate extract provided by Unicity, making results directly applicable to the product. Additionally, other Unicity studies show Unimate increases fullness by 59% within 15 minutes and reduces caloric intake by 11%.

Full Analysis

This research is among the most important recent studies in functional nutrition because it reveals the precise mechanism by which yerba mate stimulates the satiety hormone GLP-1. The study, published in the peer-reviewed journal Nutrients, shows that the effect does not occur directly but through a bacterial intermediary - dihydroferulic acid - confirming the importance of gut health in maximizing supplement benefits. The most exciting point is that this mechanism resembles what famous GLP-1 drugs (Ozempic, Wegovy, Mounjaro) do, which cost thousands of dollars monthly and require injections. Yerba mate achieves a similar effect naturally and at much lower cost. It's important to note this is a preclinical study (animals and cells), but it's supported by other human studies from Unicity showing actual effects on appetite and weight. The combination of mechanistic evidence (this study) and clinical evidence (appetite studies) provides a compelling picture of Unimate's efficacy.

Health Implications

What does this mean for your health? If you struggle with appetite control or weight management, this research offers encouraging news. Yerba mate - specifically Unimate - can stimulate the same hormone (GLP-1) targeted by the latest obesity medications, but naturally through your gut bacteria. To maximize benefits: 1. Take Unimate in the morning on an empty stomach to enhance GLP-1 effects 2. Support your gut health (probiotics and fiber) because beneficial bacteria convert compounds into their active form 3. Be patient - the study showed results after 4 weeks of regular use 4. Combine with intermittent fasting to amplify effects

Key Findings

  • Yerba mate supplementation significantly increased GLP-1 gene expression and plasma levels
  • Dihydroferulic acid (gut metabolite) increased GLP-1 secretion by more than 2.5 times
  • The effect is selective - GLP-1 increased while GIP remained unchanged
  • Gut microbiome mediates the incretin effect through ferulic acid metabolism
  • Yerba mate extract was provided by Unicity International (same as Unimate)

DOI: 10.3390/nu17040625

View Original Study